LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap
IndustriesProteomics
ManufacturerThermo Fisher Scientific
Significance of the topic
Phosphorylation is a fundamental regulator of cellular processes such as signal transduction, cell cycle progression, and metabolism. However, low stoichiometry and the heterogeneity of mono- versus multiply phosphorylated peptides present analytical challenges. Robust enrichment workflows are essential to achieve comprehensive phosphoproteome coverage.
Objectives and Study Overview
This study compares two sequential enrichment strategies: SMOAC (TiO2 followed by Fe-NTA) and SIMAC (Fe-NTA followed by TiO2), using Thermo Scientific HiSelect phosphopeptide enrichment kits. It also assesses the impact of high-pH reversed-phase fractionation after SMOAC to enhance phosphopeptide identification depth.
Methodology
Nocodazole-arrested HeLa cells were lysed, reduced, alkylated, and digested with Trypsin/Lys-C. For SMOAC, TiO2 chromatography was performed first; flow-through and wash fractions were pooled and subjected to Fe-NTA enrichment. SIMAC reversed this order. Selected samples were labeled with TMTzero. Combined SMOAC eluates underwent high-pH reversed-phase spin column fractionation. Enriched peptides were analyzed by LC–MS/MS on an Orbitrap Fusion with SEQUEST HT and phosphoRS site localization.
Used Instrumentation
- Thermo Scientific Orbitrap Fusion Tribrid mass spectrometer
- Thermo Scientific HiSelect TiO2 and Fe-NTA phosphopeptide enrichment kits
- High-pH reversed-phase spin columns
- Thermo Scientific EASY-Spray C18 nanoLC system
Main Results and Discussion
SMOAC achieved >90% phosphopeptide selectivity, identifying approximately 9 460 mono-, 3 908 di-, and 839 tri-phosphorylated peptides. SIMAC yielded fewer multiply phosphorylated species. High-pH fractionation after SMOAC added ~10 000 unique phosphopeptides, increasing coverage by ~50%. In TMTzero experiments, SMOAC alone identified ~22 000 unique phosphopeptides; fractionation increased this to ~32 500. Pathway analysis revealed ~25% more phosphoproteins in key signaling pathways. Detailed mapping of CDC25 isoforms uncovered novel and known phosphorylation sites, demonstrating enhanced depth.
Benefits and Practical Applications
SMOAC provides superior enrichment of multiply phosphorylated peptides, aiding detailed signaling and cell cycle studies. Coupling with fractionation enables deeper phosphoproteome profiling, supporting biomarker discovery and drug target validation.
Future Trends and Opportunities
Emerging metal-oxide materials, optimized buffer systems, and multidimensional fractionation are expected to further improve selectivity and depth. Integration with quantitative labeling, data-independent acquisition, and AI-driven data analysis will enable more comprehensive phosphoproteomics.
Conclusion
The SMOAC strategy, especially when combined with high-pH reversed-phase fractionation, offers a robust, high-depth approach for enriching and analyzing multiply phosphorylated peptides, outperforming traditional workflows.
References
1. Thingholm TE, Jensen ON, Robinson PJ, Larsen MR. SIMAC (Sequential Elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics. 2008;7(4):661–671.
2. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J, Hunt DF, White FM. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol. 2002;20:301–305.
3. Abe S, Nagasaka K, Hirayama Y, et al. The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II. Genes Dev. 2011;25(8):863–874.
4. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA. 2008;105(30):10762–10767.
5. Sharma K, D’Souza RCJ, Tyanova S, Schaab C, Wisniewski JR, Cox J. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014;8(5):1583–1595.
6. Chan PM, Ng YW, Manser E. A robust protocol to map binding sites of the 14-3-3 interactome: Cdc25C requires phosphorylation of both S216 and S263 to bind 14-3-3. Mol Cell Proteomics. 2011;10(3):M110.005157.
7. Esmenjaud-Mailhat C, Lobjois V, Froment C, Golsteyn RM, Monsarrat B, Ducommun B. Phosphorylation of CDC25C at S263 controls its intracellular localisation. FEBS Lett. 2007;581(21):3979–3985.
8. Jensen SS, Larsen MR. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Commun Mass Spectrom. 2007;21:3635–3645.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.